Institution · Colorado Kidney Care
Most cited papers from Colorado Kidney Care
What are the most cited papers from Colorado Kidney Care?
The most cited paper from Colorado Kidney Care is "Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients" (Francesco Locatelli, Steven N. Fishbane, Geoffrey A. Block et al., 2017), with 4,818 citations. Next come "Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis" (2,697) and "Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis" (1,141).
Showing 50 of 60 papers. Every paper with more than 103 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients Francesco Locatelli, Steven N. Fishbane, Geoffrey A. Block et al. · American Journal of Nephrology | 2017 | 4,818 |
| 2 | Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis Geoffrey A. Block, Preston Klassen, J. Michael Lazarus et al. · Journal of the American Society of Nephrology | Aug 2004 | 2,697 |
| 3 | Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis Geoffrey A. Block et al. · New England Journal of Medicine | 7 Apr 2004 | 1,141 |
| 4 | Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters Markus Ketteler, Geoffrey A. Block, Pieter Evenepoel et al. · Kidney International | 21 Jun 2017 | 1,023 |
| 5 | Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis Geoffrey A. Block, David M. Spiegel, James Ehrlich et al. · Kidney International | 13 Sep 2005 | 813 |
| 6 | Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients Geoffrey A. Block, Paolo Raggi, Antonio Bellasi et al. · Kidney International | 4 Jan 2007 | 797 |
| 7 | Sugar, Uric Acid, and the Etiology of Diabetes and Obesity Richard J. Johnson, Takahiko Nakagawa, Laura Gabriela Sánchez‐Lozada et al. · Diabetes | 17 Sep 2013 | 764 |
| 8 | Uric acid and chronic kidney disease: which is chasing which? Richard J. Johnson, Takahiko Nakagawa, Diana I. Jalal et al. · Nephrology Dialysis Transplantation | 29 Mar 2013 | 660 |
| 9 | Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: Recommendations for a change in management Geoffrey A. Block, Friedrich K. Port · American Journal of Kidney Diseases | Jun 2000 | 598 |
| 10 | Effects of Phosphate Binders in Moderate CKD Geoffrey A. Block, David Collins. Wheeler, Martha S. Persky et al. · Journal of the American Society of Nephrology | 20 Jul 2012 | 543 |
| 11 | Sodium Zirconium Cyclosilicate in Hyperkalemia David Packham, Henrik Sandvad Rasmussen, Philip T. Lavin et al. · New England Journal of Medicine | 21 Nov 2014 | 505 |
| 12 | A single-dose study of denosumab in patients with various degrees of renal impairment Geoffrey A. Block, Henry G. Bone, Liang Fang et al. · Journal of Bone and Mineral Research | 28 Mar 2012 | 342 |
| 13 | Heat stress, dehydration, and kidney function in sugarcane cutters in El Salvador – A cross-shift study of workers at risk of Mesoamerican nephropathy Ramón Gárcía-Trabanino, Emmanuel Ricardo Jarquin, Catharina Wesseling et al. · Environmental Research | 23 Jul 2015 | 336 |
| 14 | Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder: Synopsis of the Kidney Disease: Improving Global Outcomes 2017 Clinical Practice Guideline Update Markus Ketteler, Geoffrey A. Block, Pieter Evenepoel et al. · Annals of Internal Medicine | 19 Feb 2018 | 320 |
| 15 | Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism Geoffrey A. Block, David A. Bushinsky, Sunfa Cheng et al. · JAMA | 10 Jan 2017 | 317 |
| 16 | A Practical Approach to Nutrition, Protein-Energy Wasting, Sarcopenia, and Cachexia in Patients with Chronic Kidney Disease Ramy Magdy Hanna, Lena Ghobry, Olivia Wassef et al. · Blood Purification | 18 Dec 2019 | 313 |
| 17 | Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial Brad H. Rovin et al. · The Lancet | 3 Nov 2023 | 300 |
| 18 | A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy Mohit Mathur, Jonathan Barratt, Bobby Chacko et al. · New England Journal of Medicine | 2 Nov 2023 | 217 |
| 19 | Effects of Cinacalcet on Fracture Events in Patients Receiving Hemodialysis Sharon M. Moe, Safa Abdalla, Glenn Matthew Chertow et al. · Journal of the American Society of Nephrology | 12 Dec 2014 | 213 |
| 20 | Immunosuppression with Belatacept-Based, Corticosteroid-Avoiding Regimens in De Novo Kidney Transplant Recipients R M Ferguson, Josep M. Grinyo, Flavio G. Vincenti et al. · American Journal of Transplantation | 29 Nov 2010 | 210 |
| 21 | Correlation of simple imaging tests and coronary artery calcium measured by computed tomography in hemodialysis patients Antonio Bellasi, Emiliana Ferramosca, Paul Muntner et al. · Kidney International | 6 Sep 2006 | 202 |
| 22 | Heat Stress Nephropathy From Exercise-Induced Uric Acid Crystalluria: A Perspective on Mesoamerican Nephropathy Carlos A. Roncal-Jiménez, Ramón Gárcía-Trabanino, Lars Barregård et al. · American Journal of Kidney Diseases | 21 Oct 2015 | 200 |
| 23 | DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS Howard Trachtman et al. · Journal of the American Society of Nephrology | 25 Oct 2018 | 186 |
| 24 | Association of pulse wave velocity with vascular and valvular calcification in hemodialysis patients Paolo Raggi, Antonio Bellasi, Emiliana Ferramosca et al. · Kidney International | 21 Feb 2007 | 180 |
| 25 | Medicare Costs Associated With Arteriovenous Fistulas Among US Hemodialysis Patients Mae Thamer, Timmy C. Lee, Haimanot Wasse et al. · American Journal of Kidney Diseases | 28 Mar 2018 | 171 |
| 26 | Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study Melanie P. Chin, George L. Bakris, Geoffrey A. Block et al. · American Journal of Nephrology | 2018 | 165 |
| 27 | Pathogenesis, diagnosis and management of paraneoplastic glomerulonephritis Yeong-Hau Howard Lien, Li-Wen Lai · Nature Reviews Nephrology | 14 Dec 2010 | 163 |
| 28 | Effect of Etelcalcetide vs Placebo on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism Geoffrey A. Block, David A. Bushinsky, John Alastair Cunningham et al. · JAMA | 10 Jan 2017 | 160 |
| 29 | Lifestyle-Related Factors, Obesity, and Incident Microalbuminuria: The CARDIA (Coronary Artery Risk Development in Young Adults) Study Alex R. Chang, Linda Van Horn, David R. Jacobs et al. · American Journal of Kidney Diseases | 18 Apr 2013 | 160 |
| 30 | Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE) Glenn Matthew Chertow, Lara B. Pupim, Geoffrey A. Block et al. · Clinical Journal of the American Society of Nephrology | 16 Aug 2007 | 158 |
| 31 | Blood Calcification Propensity, Cardiovascular Events, and Survival in Patients Receiving Hemodialysis in the EVOLVE Trial Andreas Pasch, Geoffrey A. Block, Matthias Bachtler et al. · Clinical Journal of the American Society of Nephrology | 9 Dec 2016 | 155 |
| 32 | Loop Diuretic Infusion Increases Thiazide-Sensitive Na+/Cl--Cotransporter Abundance Joseph G. Abdallah, Robert W. Schrier, Charles L. Edelstein et al. · Journal of the American Society of Nephrology | Jul 2001 | 155 |
| 33 | Cinacalcet hydrochloride treatment significantly improves all-cause and cardiovascular survival in a large cohort of hemodialysis patients Geoffrey A. Block, David A. Zaun, Gerard Smits et al. · Kidney International | 16 Jun 2010 | 155 |
| 34 | A 12-Week, Double-Blind, Placebo-Controlled Trial of Ferric Citrate for the Treatment of Iron Deficiency Anemia and Reduction of Serum Phosphate in Patients With CKD Stages 3-5 Geoffrey A. Block, Steven N. Fishbane, Mariano Rodríguez et al. · American Journal of Kidney Diseases | 4 Nov 2014 | 152 |
| 35 | Clinical Outcomes after Parathyroidectomy in a Nationwide Cohort of Patients on Hemodialysis Areef Ishani, Jiannong Liu, James B. Wetmore et al. · Clinical Journal of the American Society of Nephrology | 17 Dec 2014 | 143 |
| 36 | Effects of Cinacalcet on Atherosclerotic and Nonatherosclerotic Cardiovascular Events in Patients Receiving Hemodialysis: The EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) Trial David Collins. Wheeler, Gerard Michel London, Patrick S. Parfrey et al. · Journal of the American Heart Association | 17 Nov 2014 | 141 |
| 37 | Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD Tamara Isakova, Joachim H. Ix, Stuart Michael Sprague et al. · Journal of the American Society of Nephrology | 12 May 2015 | 133 |
| 38 | Ferric Citrate Hydrate for the Treatment of Hyperphosphatemia in Nondialysis-Dependent CKD Keitaro Yokoyama, Hideki Hirakata, Takashi Akiba et al. · Clinical Journal of the American Society of Nephrology | 9 Jan 2014 | 133 |
| 39 | 876 EUS guided Gastrojejunostomy versus Laparoscopic Gasrojejunostomy: An International Collaborative Study Manuel Pérez‐Miranda, Amy Tyberg, Reem Z. Sharaiha et al. · Gastrointestinal Endoscopy | May 2016 | 128 |
| 40 | A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Cinacalcet HCl in Participants With CKD Not Receiving Dialysis Michel Chonchol, Francesco Locatelli, H. E. Abboud et al. · American Journal of Kidney Diseases | 25 Dec 2008 | 125 |
| 41 | Antihypertensive therapy in type 2 diabetes: implications of the appropriate blood pressure control in diabetes (ABCD) trial Raymond O. Estacio, Robert W. Schrier · The American Journal of Cardiology | Nov 1998 | 124 |
| 42 | High Prevalence of Obstructive Sleep Apnea and Its Association with Renal Function among Nondialysis Chronic Kidney Disease Patients in Japan Yusuke Sakaguchi, Tatsuya Shoji, Hiroaki Kawabata et al. · Clinical Journal of the American Society of Nephrology | 18 Mar 2011 | 123 |
| 43 | Efficacy and Safety of Tenapanor in Patients with Hyperphosphatemia Receiving Maintenance Hemodialysis: A Randomized Phase 3 Trial Geoffrey A. Block, David P. Rosenbaum, Andrew Tze-Kay Yan et al. · Journal of the American Society of Nephrology | 7 Mar 2019 | 121 |
| 44 | Effects of Ferric Citrate in Patients with Nondialysis-Dependent CKD and Iron Deficiency Anemia Steven N. Fishbane, Geoffrey A. Block, Lisa Carole Loram et al. · Journal of the American Society of Nephrology | 12 Jan 2017 | 121 |
| 45 | CKD–Mineral and Bone Disorder and Risk of Death and Cardiovascular Hospitalization in Patients on Hemodialysis Geoffrey A. Block, Ryan D. Kilpatrick, Kimberly Anne Lowe et al. · Clinical Journal of the American Society of Nephrology | 20 Sep 2013 | 121 |
| 46 | Drug-Eluting Resorbable Scaffold versus Angioplasty for Infrapopliteal Artery Disease Ramon L. Varcoe et al. · New England Journal of Medicine | 25 Oct 2023 | 120 |
| 47 | EFFECT OF PRE- AND POSTOPERATIVE PLASMAPHERESIS ON POSTTRANSPLANT RECURRENCE OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS IN CHILDREN Toshiyuki Ohta, Hiroshi Kawaguchi, Motoshi Hattori et al. · Transplantation | Mar 2001 | 120 |
| 48 | DRB1*15 Allele Is a Risk Factor for PR3-ANCA Disease in African Americans Yali Cao, John L. Schmitz, Jiajin Yang et al. · Journal of the American Society of Nephrology | 26 May 2011 | 118 |
| 49 | Guidelines for Venous Access in Patients with Chronic Kidney Disease Jeffrey G. Hoggard, Theodore F. Saad, Don Schon et al. · Seminars in Dialysis | Mar 2008 | 118 |
| 50 | Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis Michelle N. Rheault et al. · New England Journal of Medicine | 3 Nov 2023 | 117 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.